MucinB5 Gene Polymorphism and Leucocytes Telomere Length in Interstitial Lung Diseases
Recruiting
Observational Study
Mucin B5 rs (35705950) Gene Polymorphism in Interstitial Lung Diseases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Sohag University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is an observertional study aimed at Study the association between Mucin B5 rs (35705950) gene polymorphism and Leucocytes telomere length in relation to interstitial lung diseases.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
This study will include patients with interstitial lung diseases aged above 18 years old.
Exclusion Criteria:
* patients with emphysema or obstructive lung diseases.
* patients with active cancer
* End stage renal failure (GFR \< 30 ml/min) or on dialysis
* Liver cell failure
Contacts